Sodium-glucose co-transporter 2 inhibitor canagliflozin modulates myocardial metabolism and inflammation in a swine model for chronic myocardial ischemia

This study investigated the effects of canagliflozin therapy on metabolic pathways and inflammation in ischemic myocardial tissue using a swine model of chronic myocardial ischemia.

Source: Surgery - November 6, 2023 Category: Surgery Authors: Dwight D. Harris, Sharif A. Sabe, Cynthia M. Xu, Mohamed Sabra, Mark Broadwin, Akshay Malhotra, Janelle W. Li, M. Ruhul Abid, Frank W. Sellke Source Type: research